Localized Delivery of Amifostine Enhances Salivary Gland Radioprotection

Radiotherapy for head and neck cancers commonly causes damage to salivary gland tissue, resulting in xerostomia (dry mouth) and numerous adverse medical and quality-of-life issues. Amifostine is the only Food and Drug Administration–approved radioprotective drug used clinically to prevent xerostomia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Dent Res
Main Authors: Varghese, J.J., Schmale, I.L., Mickelsen, D., Hansen, M.E., Newlands, S.D., Benoit, D.S.W., Korshunov, V.A., Ovitt, C.E.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Research Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151913/
https://ncbi.nlm.nih.gov/pubmed/29634396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034518767408
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados